Oxford Finance leads $30 million credit facility provided to Cadence for launch of OFIRMEV
Friday, July 30th, 2010
More info…
Oxford Finance Corporation, a subsidiary of Sumitomo Corporation, today announced that it was the lead lender for a $30 million credit facility provided to Cadence Pharmaceuticals. Silicon Valley Bank and GE Financial Services, Inc. also participated in the loan agreement. This infusion of capital will support the company’s potential launch of their investigational product candidate, OFIRMEV …










